-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Ambrx Biopharma Cayman, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q1 2022 to Q2 2023.
- Ambrx Biopharma Cayman, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending June 30, 2023 was $1.12M, a 13.5% decline year-over-year.
- Ambrx Biopharma Cayman, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $7.4M, a 0.71% decline from 2021.
- Ambrx Biopharma Cayman, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $7.46M, a 45.5% decline from 2020.
- Ambrx Biopharma Cayman, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2020 was $13.7M, a 32.6% increase from 2019.
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)